Evidence map›Paper›PMID 29804259›Full record

ArticleJournal of materials science. Materials in medicine2018

Novel alginate biphasic scaffold for osteochondral regeneration: an in vivo evaluation in rabbit and sheep models.

Giuseppe Filardo, Francesco Perdisa, Michael Gelinsky, Florian Despang, Milena Fini, Maurilio Marcacci, Anna Paola Parrilli, Alice Roffi, Francesca Salamanna, Maria Sartori and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Tissue engineering of the larynx: A contemporary review.Journal of clinical laboratory analysis · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Scaffolds and coatings for bone regeneration.Journal of materials science. Materials in medicine · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Giuseppe FilardoNano-Biotechnology (NABI) Laboratory, Rizzoli RIT Department, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, Bologna, 40136, Italy.
Francesco PerdisaNano-Biotechnology (NABI) Laboratory, Rizzoli RIT Department, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, Bologna, 40136, Italy. dr.perdisa@gmail.com.ORCID http://orcid.org/0000-0002-5522-4744
Michael GelinskyCentre for Translational Bone, Joint and Soft Tissue Research, University Hospital and Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 73, Dresden, 01307, Germany.
Florian DespangCentre for Translational Bone, Joint and Soft Tissue Research, University Hospital and Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 73, Dresden, 01307, Germany.
Milena FiniLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Rizzoli RIT Department, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, Bologna, 40136, Italy.
Maurilio MarcacciKnee Joint Reconstruction Center - 3rd Orthopaedic Division, Humanitas Clinical Institute, Via Alessandro Manzoni 56, Rozzano, Milan, Italy.
Anna Paola ParrilliLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Rizzoli RIT Department, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, Bologna, 40136, Italy.
Alice RoffiNano-Biotechnology (NABI) Laboratory, Rizzoli RIT Department, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, Bologna, 40136, Italy.
Francesca SalamannaLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Rizzoli RIT Department, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, Bologna, 40136, Italy.
Maria SartoriLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Rizzoli RIT Department, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, Bologna, 40136, Italy.
Kathleen SchützCentre for Translational Bone, Joint and Soft Tissue Research, University Hospital and Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 73, Dresden, 01307, Germany.
Elizaveta KonKnee Joint Reconstruction Center - 3rd Orthopaedic Division, Humanitas Clinical Institute, Via Alessandro Manzoni 56, Rozzano, Milan, Italy.

Funding

European project FP7-NMP-2009-SMALL 3-246373
6 · The paper itself

Abstract

Current therapeutic strategies for osteochondral restoration showed a limited regenerative potential. In fact, to promote the growth of articular cartilage and subchondral bone is a real challenge, due to the different functional and anatomical properties. To this purpose, alginate is a promising biomaterial for a scaffold-based approach, claiming optimal biocompatibility and good chondrogenic potential. A previously developed mineralized alginate scaffold was investigated in terms of the ability to support osteochondral regeneration both in a large and medium size animal model. The results were evaluated macroscopically and by microtomography, histology, histomorphometry, and immunohistochemical analysis. No evidence of adverse or inflammatory reactions was observed in both models, but limited subchondral bone formation was present, together with a slow scaffold resorption time.The implantation of this biphasic alginate scaffold provided partial osteochondral regeneration in the animal model. Further studies are needed to evaluate possible improvement in terms of osteochondral tissue regeneration for this biomaterial.

Indexed as

Bone RegenerationAlginatesAnimalsBiocompatible MaterialsBone and BonesCartilage, ArticularChondrogenesisCollagenGlucuronic AcidHexuronic AcidsImmunohistochemistryInflammationMaleOsteocytesOsteogenesisRabbitsAlginatesBiocompatible MaterialsCollagenGlucuronic AcidHexuronic Acids

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.